Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Remyelinating strategies in multiple sclerosis.
The pill times 2: What every woman with multiple sclerosis should know.
Multiple sclerosis guideline production takes off.
Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).]
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Gene set differential analysis of time course expression profiles via sparse estimation in functional logistic model with application to time-dependent biomarker detection.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
The therapeutic use of cannabinoids: Forensic aspects.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »